Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Forward Pharma A/S    FWP

FORWARD PHARMA A/S

(FWP)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/12/2019 04/15/2019 04/16/2019 04/17/2019 04/18/2019 Date
1.23(c) 1.18(c) 1.2(c) 1.18(c) 1.18(c) Last
2 438 5 001 1 493 1 207 3 329 Volume
+2.15% -4.07% +1.69% -1.67% 0.00% Change
More quotes
Company
Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate,... 
More about the company
Latest news on FORWARD PHARMA A/S
04/04Forward Pharma Reports Financial and Operational Results from the Year Ended ..
GL
03/28FORWARD PHARMA A/S : to Participate in the DKBIO2019 Life Science Investor Confe..
AQ
03/27Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conferen..
GL
2018FORWARD PHARMA A/S : Provides Update on the Decision of the Federal Circuit in i..
AQ
2018Forward Pharma Provides Update on the Decision of the Federal Circuit in its ..
GL
2018Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Confe..
GL
2018Forward Pharma Reports Financial and Operational Results from the First Six M..
GL
2018FORWARD PHARMA A/S : to Participate in the LSX Nordic Congress
AQ
2018FORWARD PHARMA A/S : to Participate in the LSX Nordic Congress
AQ
2018FORWARD PHARMA A/S : Appeals the Decision of the Opposition Division to Revoke t..
AQ
More news
Analyst Recommendations on FORWARD PHARMA A/S
More recommendations
Sector news : Bio Therapeutic Drugs
04/16GILEAD SCIENCES : Insitro to Collaborate on Nonalcoholic Steatohepatitis
DJ
04/15PATRICK THOMAS : Novartis Files Application for Macular Degeneration Treatment
DJ
04/12GILEAD SCIENCES : Novo Nordisk Plan NASH Collaboration
DJ
04/08GSK wins U.S. nod for two-drug HIV combination
RE
04/08Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance
DJ
More sector news : Bio Therapeutic Drugs
Chart FORWARD PHARMA A/S
Duration : Period :
Forward Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORWARD PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Managers
NameTitle
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Schönharting Chairman
Torsten Rüdiger Goesch Director
Grant Hellier Lawrence Independent Director
Jakob Mosegaard Larsen Director
Sector and Competitors
1st jan.Capitalization (M$)
FORWARD PHARMA A/S51.28%56
GILEAD SCIENCES0.64%80 255
VERTEX PHARMACEUTICALS1.48%42 991
REGENERON PHARMACEUTICALS-10.75%35 789
GENMAB5.11%10 418
SAREPTA THERAPEUTICS INC6.88%8 594